Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:COTY
NYSE:COTYPersonal Products

Is Coty a Value Opportunity After a 53% Share Price Slide?

If you are wondering whether Coty is a beaten down value opportunity or a value trap at today’s price, this article will walk you through what the numbers really say. The stock has barely budged in the short term, up 1.2% over the past week and just 0.3% over the last month. However, zooming out shows a much rougher ride, with the share price down 52.5% year to date and 53.7% over the last year. Those steep longer term declines reflect a mix of investor concerns around the pace of Coty’s...
SEHK:2142
SEHK:2142Biotechs

HBM Holdings (SEHK:2142): Valuation Check After Bristol Myers Squibb Collaboration Validates Growth Prospects

HBM Holdings (SEHK:2142) just landed a multi year global collaboration and license deal with Bristol Myers Squibb, tying its antibody discovery platform to potentially more than $1.1 billion in future payments. See our latest analysis for HBM Holdings. The market has already started to reprice that validation, with a 1 day share price return of 6.6 percent pushing HBM Holdings to HK$13.34. Its roughly 574 percent year to date share price return and nearly 896 percent 1 year total shareholder...
ASX:SGR
ASX:SGRHospitality

Star Entertainment Group (ASX:SGR): Valuation Check After Major Boardroom Overhaul and Leadership Reshuffle

Star Entertainment Group (ASX:SGR) has kicked off a fresh chapter after a packed December board meeting reshaped its leadership, with Bruce Mathieson Jnr moving from chairman to CEO and Soo Kim taking the chair. See our latest analysis for Star Entertainment Group. The leadership shake up and Bally's backed recapitalisation have given the stock fresh momentum, with a 30 day share price return of 52.94% contrasting sharply with a still deeply negative five year total shareholder return of...
NasdaqGS:CHA
NasdaqGS:CHAHospitality

Is Chagee Holdings (CHA) Using ESG And Health Branding To Build A Defensible Tea Empire?

In 2025, Chagee Holdings released its inaugural 2024 Sustainability Report and continued expanding across Asia Pacific, now operating over 7,338 tea houses in markets including Indonesia, the Philippines, Vietnam, Singapore, Malaysia, and Thailand. By pairing ESG-focused initiatives with health certifications and culturally tailored product innovation, the company is positioning its modern tea brand to appeal to both socially conscious and health-oriented consumers across the region. We’ll...
ASX:NVA
ASX:NVAMetals and Mining

Nova Minerals (ASX:NVA): Evaluating Valuation After the Latest Follow-On Equity Offering and Funding Boost

Nova Minerals (ASX:NVA) just wrapped up a roughly A$20 million follow on equity offering in its American Depositary Shares, a capital raise that directly shapes how it funds the next phase of its growth plans. See our latest analysis for Nova Minerals. The fresh capital raise lands after a busy few weeks, including a US shelf registration and conference appearance. It comes as Nova’s 90 day share price return of 152.11 percent and 1 year total shareholder return of 179.69 percent signal...
NYSE:OWLT
NYSE:OWLTMedical Equipment

Did Owlet’s (OWLT) New Insurance-Backed BabySat Deal Just Shift Its Healthcare-Channel Narrative?

Earlier this month, Owlet, Inc. announced a new DME partnership with 1 Natural Way, allowing families across the U.S. to access its FDA-cleared BabySat pulse oximeter through insurance-supported channels, including commercial plans, many state Medicaid networks, and TRICARE. This expansion into reimbursed home monitoring for higher-risk infants underlines Owlet’s push further into clinically integrated, insurance-backed distribution rather than relying solely on direct-to-consumer...
TSX:TA
TSX:TARenewable Energy

TransAlta (TSX:TA) Valuation Revisited After Centralia Extension Order and US$400 Million Senior Notes Issue

TransAlta (TSX:TA) has landed back on investors radar after two intertwined developments: a three month federal order keeping its Centralia Unit 2 coal plant online and a US$400 million senior note issue to bolster flexibility. See our latest analysis for TransAlta. Despite the headline noise around Centralia and the new senior notes, the share price has drifted to about CA$17.25, with a roughly 15 percent year to date share price decline contrasting with a still impressive five year total...
NYSE:NKE
NYSE:NKELuxury

Nike (NKE) Q2 2026 Margin Compression Reinforces Bearish Profitability Narratives

Nike (NKE) just posted its Q2 2026 numbers, with revenue at $12.4 billion, basic EPS of $0.54 and net income of $792 million setting the tone for the latest quarter. The company has seen revenue move from $12.4 billion in Q2 2025 to $12.4 billion in Q2 2026, while basic EPS shifted from $0.78 to $0.54 over the same period, giving investors plenty to dissect around how underlying margins are tracking. See our full analysis for NIKE. With the headline figures on the table, the next step is to...